Andrés Finzi

Andrés Finzi is a Full Professor and Canada Research Chair in Retroviral Entry at the Université de Montréal's Faculty of Medicine, Department of Microbiology, Infectious Diseases and Immunology. He leads the Retroviral Entry Lab at the CRCHUM and is internationally recognized for his work on HIV-1 entry mechanisms and antibody-based therapies. His research focuses on developing HIV entry inhibitors, designing immunogens for vaccines, and understanding immune evasion strategies of HIV and SARS-CoV-2.

Education:

• PhD in Virology, Université de Montréal
• Postdoctoral training at Dana-Farber Cancer Institute/Harvard Medical School

Research Interests:

• Mechanisms of HIV/SARS-CoV-2 entry into host cells
• Antibody-dependent cellular cytotoxicity (ADCC) and immune evasion
• Development of novel antiviral strategies and vaccines

His work bridges structural virology, immunology, and translational medicine to combat viral infections.

Key Awards:

• 2019 Joe-Doupe Young Investigator Award
• 2020 Royal Society of Canada College Membership
• Mathilde Krim Fellowship (amfAR)

Grants & Collaborations:

• NIH, CIHR, and Bill & Melinda Gates Foundation funding
• Leadership in multi-institutional projects targeting HIV cure strategies and SARS-CoV-2 immunity

Labs & Teams:

• Retroviral Entry Lab at CRCHUM
• Collaborations with global teams studying viral pathogenesis and immunotherapies